Fundamentals screen · refreshed after the Sep 28, 2026 close

Net-cash companies

Companies whose cash and investments exceed all debt by at least a quarter of their market value. Net cash is cash plus short-term investments minus debt, from the latest quarterly balance sheet.

CriteriaNet cash ≥ 25% of market capMarket cap ≥ $300MCommon stock487 stocks
#CompanyPriceNet cashMkt capRevenue YoYP/E
451MOVMovado GroupHealthcare$33.48$211.6M$747.0M+4.9%18.1×
452IMMXImmix BiopharmaHealthcare$11.47$232.1M$820.6M——
453USARUSA Rare EarthMaterials$14.42$1.53B$5.41B——
454QUREuniQureHealthcare$39.11$760.2M$2.71B+11.0%—
455PBLSParabilis MedicinesHealthcare$32.57$1.11B$4.02B——
456RSKDRiskifiedUnclassified$7.70$280.3M$1.02B——
457ANNXAnnexonHealthcare$4.01$209.2M$760.2M——
458NTLAIntellia TherapeuticsHealthcare$11.42$437.8M$1.60B−46.2%—
459RAPPRapport TherapeuticsHealthcare$33.44$436.1M$1.60B——
460CLYMClimb BioHealthcare$11.74$183.1M$674.3M——
461ERIIEnergy RecoveryTechnology$6.72$93.1M$343.0M−57.2%22.4×
462ACADAcadia PharmaceuticalsHealthcare$20.53$956.5M$3.54B+16.4%9.3×
463SGPSpyGlass PharmaHealthcare$25.98$234.2M$869.0M——
464AVLNAvalyn PharmaHealthcare$28.32$337.6M$1.26B——
465VRDNViridian TherapeuticsHealthcare$20.57$625.7M$2.33B+278.7%—
466LBRXLB PharmaceuticalsHealthcare$37.89$327.8M$1.22B——
467DSGNDesign TherapeuticsHealthcare$12.36$207.4M$773.5M——
468RXRXRecursion PharmaceuticalsHealthcare$3.70$531.5M$1.98B−60.1%—
469RZLTRezolute, Inc. Common Stock (NV)Healthcare$4.18$107.8M$404.3M——
470NEXNNexxen InternationalUnclassified$8.78$133.3M$500.0M——
471REXREX American ResourcesMaterials$42.61$376.4M$1.41B+17.9%11.7×
472SSRMSSR MiningFinancials$33.84$1.83B$6.90B+9.5%29.0×
473ELVNEnliven TherapeuticsHealthcare$46.01$895.2M$3.37B——
474IPGPIPG PhotonicsTechnology$77.23$871.3M$3.28B+11.1%119.2×
475UMACUnusual MachinesTechnology$23.96$316.4M$1.20B+687.3%—
476IRONDisc MedicineHealthcare$64.92$658.4M$2.49B——
477XENEXenon PharmaceuticalsHealthcare$36.72$930.7M$3.56B——
478SPTXSeaport TherapeuticsHealthcare$19.64$273.3M$1.05B——
479FTHFaeth TherapeuticsHealthcare$27.77$186.4M$717.6M——
480AVBPArriVent BioPharmaHealthcare$29.30$373.1M$1.44B——
481TROWT Rowe Price GroupFinancials$103.81$5.71B$22.14B+10.7%10.2×
482TNKTeekay TankersUnclassified$95.71$852.6M$3.32B——
483JOBYJoby AviationConsumer Discretionary$6.11$1.56B$6.09B+257493.3%—
484TTDThe Trade DeskTechnology$12.34$1.49B$5.83B+3.0%14.3×
485FRHCFreedom HoldingFinancials$174.37$2.81B$11.12B+20.5%71.9×
486VINPVinci Compass InvestmentsUnclassified$9.29$153.7M$609.9M——
487UPWKUpworkTechnology$8.07$253.6M$1.01B−1.7%9.8×

Method & sources

Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology

Informational screen, not a recommendation.

Net-cash companies (Sep 28) | Gainbot